frontotemporal dementia

frontotemporal dementia. Frontotemporal dementia is a group of neurodegenerative disorders characterized by progressive damage to the frontal lobe and temporal lobe of the brain. This condition leads to significant changes in personality, behavior, and language abilities, distinct from the memory loss prominent in Alzheimer's disease. It is a leading cause of early-onset dementia, often diagnosed in individuals under the age of 65.

Signs and symptoms

Clinical presentation varies significantly based on the specific regions of the cerebral cortex most affected. The behavioral variant primarily involves profound changes in personality and conduct, such as apathy, disinhibition, loss of empathy, and compulsive behaviors, often assessed using tools like the Frontal Assessment Battery. Primary progressive aphasia subtypes include semantic variant, marked by loss of word and object meaning, and nonfluent variant, characterized by effortful, agrammatic speech. Associated motor symptoms can include those seen in corticobasal degeneration and amyotrophic lateral sclerosis.

Causes and pathophysiology

The underlying pathology involves the abnormal accumulation of specific proteins within neurons and glial cells in the frontal and temporal regions. The most common pathological findings are inclusions of the protein TDP-43, while others involve aggregates of tau protein or the protein FUS. A significant proportion of cases, particularly those with a strong family history, are linked to mutations in genes such as MAPT, GRN, and C9orf72. These genetic abnormalities lead to neuronal dysfunction and death, resulting in marked atrophy that is visible on neuroimaging studies like MRI.

Diagnosis

Diagnosis is primarily clinical, based on established criteria such as the International Behavioral Variant FTD Criteria and relies on detailed history-taking from patients and caregivers. Neuropsychological testing, including evaluations of executive function and language, is crucial for delineating the subtype. Structural neuroimaging with MRI typically shows characteristic asymmetric atrophy of the frontal and anterior temporal lobes. Metabolic imaging with FDG-PET often reveals hypometabolism in these same regions, helping to differentiate it from Alzheimer's disease and other conditions like vascular dementia.

Management

There are no disease-modifying treatments approved by the U.S. Food and Drug Administration or the European Medicines Agency for frontotemporal dementia. Management is symptomatic and supportive, often involving a multidisciplinary team including neurologists, psychiatrists, speech therapists, and occupational therapists. Selective serotonin reuptake inhibitors like sertraline may be used to manage behavioral symptoms such as disinhibition and compulsivity. Non-pharmacological interventions, including environmental modifications and caregiver education, are cornerstone components of care.

Prognosis

The disease follows a progressive and debilitating course, with survival times typically ranging from 6 to 10 years from symptom onset. The rate of progression can vary, often leading to a state of severe cognitive and physical disability requiring full-time care. Ultimately, common causes of death include complications from pneumonia, dysphagia, and other systemic infections. The prognosis is generally poorer than for some other dementias, with earlier age of onset often associated with more aggressive disease in certain genetic forms.

Epidemiology

Frontotemporal dementia is a relatively common cause of early-onset dementia, accounting for an estimated 5-15% of all dementia cases and up to 20% of cases presenting before age 65. Incidence rates are approximately 2-3 per 100,000 person-years, with prevalence estimated between 15-22 per 100,000 in the population aged 45-64. Studies, including those from the Mayo Clinic and the University of California, San Francisco, suggest no clear gender predominance. While most cases are sporadic, a significant minority, around 30-40%, report a family history of similar conditions. Category:Neurodegenerative disorders Category:Dementia